aortic strips, the dose-response curves for phenylephrine were obtained before and after addition of droperidol. Droperidol caused a parallel shift of the curves dose-dependently toward the right side and its grade of the shift was greater than caused by phentolamine at the same concentration. In the left atrial strip, the potentiation of contraction by tyramine was markedly depressed by droperidol. In the reserpinized preparation, the effect of tyramine was depressed markedly and there was no nor epinephrine fluorescence. After incubation with norepinephrine they were restored to the same level as in non-reserpinized preparations. However, incubation with droperidol before norepinephrine blocked the restoration. It is postulated that droperidol may have both alpha-adrenergic blocking action and inhibitory action on norepinephrine uptake by adrenergic terminals.
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The use of droperidol in clinical anesthesia is stated to confer advantages in cardiovascular stability. However, in the hypovolemic state, it produces severe hypotension. As to the mechanism of its effect there has been controversial opin ions. Corssen et al. (1964) and Whitman and Russell (1971) suggested that this was the result of alpha-adrenergic blockade. This explanation has been ques tioned by Puddy (1971) and Green (1972) , who described that droperidol was a non specific inhibitor of vasoconstriction rather than a competitive alpha-adrenergic blockade. Recently, unexplained sustained hypertension which occurred during thalamonal (mixture of droperidol 2.5 mg and fentanyl 0.05 mg/ml) anesthesia was reported (Feingold and Ivankovic 1969; Iwatsuki 1973) . But there has been no report that may explain its mechanism.
In order to solve these questions, the present study was concerned with the interaction of droperidol with phenylephrine (PE), norepinephrine (NE) , isoprote renol (ISP) and tyramine on the isolated aortic and left atrial strip of rabbit , and furthermore examined the effect of droperidol on the uptake of norepinephrine by adrenergic terminal by means of fluorescent histochemistry . Reserpine treatment and incubation with norepinephrine and droperidol . The intra peritoneal administration of 5 mg/kg of reserpine was followed by an intraperitoneal injection of 150 mg/kg of nialamide (MAO inhibitor) 22 hr later . The atrial strips were removed for study 24 hr after reserpine administration .
METHODS
These reserpinized atria were incubated with 10-6M of NE or 10-7M of droperidol in the Krebs-Henseleit solution for 15 min at 37°C and then washed out three tim es with 100 ml of the Krebs-Henseleit solution for study .
Fluorescent histochemistry examination . By means of the technique of Falek et al . (1962)
, the left atria were prepared for an observation of fluorescence induced by NE . Th e preparation was observed under a Zeiss fluorescence microscope and photographed on Fuji X-ray film. The effect of droperidol on the dose -response curve of PE and histamine . The d ose-response curves for PE were obtained before and aft er the addition of 10-9, 1 0-8 and 10-7M of droperidol . The curve for histamine was obtained before and after the addition of 10-6M of droperidol . Droperidol produced the parallel shift of the PE dose-response curve to the right side, and its grades were dependent on the concentration of droperidol (Fig. 2) . Under the same concentration (10-7M), the grade of the shift produced by droperidol was greater than that produced by phentolamine (Fig. 3) . The histamine dose-response curve was shifted to the right at a higher concentration of droperidol (10-6M) (Fig. 4) .
RESULTS

Aortic strips
Left atrial strip
Non-reserpinized preparations. Effect of droperidol on the contractile tension derived by electrical stimuli was studied.
There was a slight depression of the contractile tension by a droperidol of 10-8M. Effect of droperidol on the potentiation of contractile tension with NE, ISP and tyramine was as follows. By the pretreatment with 10-7M of droperidol, the potentiation with 10-5M of NE was slightly increased and that with 10-7M of ISP was not changed significantly. On the other hand, the potentiation with tyramine was markedly depressed by the pretreatment with 10-7M of droperidol (Table. 1 ). Table 2 ). The restoration of tyramine potentiation was not influenced by the incubation with droperidol after with NE. However, the incubation with droperidol before with NE blocked the restoration completely (Table. 2). Fluorescent histochemistry. In the reserpinized preparation there was no NE fluorescence. By the incubation with NE the intense fluorescence was observed. However, it was diminished again by the incubation with droperidol before with NE (Fig. 5) . DISCUSSION Droperidol, a neuroleptic agent, produced hypotension in man (Macdonald et al. 1966 ) and experimental animals (Yelnosky et al. 1964) . Although some papers (Corssen 1964: Whitman and Russell 1971) suggested that this was the result of alpha-adrenergic blocking action, they have not been examined on the isolated preparation basically yet. Puddy (1971) has demonstrated that droperidol blocked vasoconstriction induced by histamine and potassium as well as by NE in the isolated rabbit auricular preparations. Johnstone (1970) and Greene (1972) have shown that droperidol has a local anesthetic action in man and guinea pig. It appears that droperidol has non-specific antagonism to vasoconstriction rather than specific alpha-adrenergic antagonism. However, it is well known that alpha-adrenergic antagonists have also antihistaminic and non-specific inhibitory action under somewhat higher concentration.
In the aortic strip which is most convenient for evaluating the effect of vasoactive agents, the dose-response curve of PE, being regarded as pure alpha adrenergic agonist, was the most sensitive to droperidol and was brought in dose dependent parallel shift to the right side by droperidol (Fig. 2) . On the other hand, that of histamine was slightly shifted by 10-6M of droperidol (Fig. 4) and furthermore, potassium contraction was less depressed even at higher concentration of droperidol, such as 10-5M (Fig. 1) . Thus it is suggested that droperidol may have a specific alpha-adrenergic blocking action on the aortic strip of rabbit, which is more potent than phentolamine (Fig. 3) .
In clinical application, it is apparent that phentolamine is more potent than droperidol in respect of vasodepression, and the sustained hypertension due to droperidol in man was reported (Feingold and Ivenkovic 1969; Iwatsuki 1973 ). Therefore, droperidol seems to have an excitatory effect on the cardiovascular system in addition to its alpha-adrenergic blocking action.
In the atrial preparation, the pretreatment with droperidol caused no signifi cant change in the potentiation of contraction induced by NE and ISP. On the other hand, it reduced the tyramine potentiation markedly (Table 1) . Tyramine is one of the adrenergic agonists, which have an indirect action, being dependent on NE release from the adrenergic terminal. Thus we would propose that the inhibitory effect of droperidol on tyramine potentiation might be attributed to block either the uptake of tyramine into adrenergic terminals, or NE release from adrenergic terminals. In the reserpinized preparation, the tyramine effect was depressed markedly because of depletion of NE in the adrenergic terminals. The incubation with NE led to restoration of essentially normal sensitivity of atria to tyramine. This restoration, however, was completely blocked by the incubation with droperidol before with NE (Table. 2).
The neuronal uptake of tyramine takes place in the same way as that of NE (Smith 1973) . Therefore, droperidol may be able to block the uptake of NE as well as tyramine into the adrenergic terminals. This suggestion was examined directly by means of the method of fluorescent histochemistry. The incubation of reserpinized preparations with NE led to restoration of intense NE fluorescence.
But there was only a slight fluorescence in the reserpinized preparation incubated with droperidol before with NE (Fig. 5 ). The incubation with NE leads to repletion of NE store not only in the adrenergic terminal, but also in the myocardial cell. However, it is necessary to incubate with somewhat higher concentration of NE in order to get enough repletion of NE in the myocardial cell, and NE in the myocardial cell is easily diminished after thorough washout, because it is less stable than that in the adrenergic terminal (Avakian and Gillespie 1968). Therefore it seems likely that the restoration of tyramine effect and NE fluorescence in the reserpinized atrium with NE incubation is due to NE taken up not into the myocardium, but into the adrenergic terminal, and droperidol may inhibit NE uptake into the adrenergic terminal.
The adrenergic blocking agents, such as phentolamine, phenoxybenzam.me and propranolol, can also inhibit the NE uptake; in the isolated rat heart, concentra tions being required to produce 50% inhibition of NE uptake were 10-5 to 10-6 M (Iversen 1975 of droperidol (Droleptan) in the study. Its solvent contains lactic acid, methyl -p-hydrobenzoate and propyl-p-hydroxybenzonate. The solvent was examined as to whether it affects the potentiating effect of tyramine on atrial contraction or not. As shown in Table 3 , the tyramine potentiation was not influenced at all by pre treatment with the solvent.
